BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» In the clinic for Dec. 2, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
In the clinic for Dec. 2, 2021
Dec. 2, 2021
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Acadia, Accutar, Arch, Biogen, Ciclomed, Clene, Compass, Edesa, G1, Immunomic, Insilico, J&J, Lintonpharm, Longeveron, Lynk, Mina, Modus, Notable, Oncotelic, Peptilogics, Pulmotech, Rallybio, SAB, Sage, Scholar Rock, Selecta, Sobi, Vertex, Virios, Zai, Zymeworks.
BioWorld
Briefs
Clinical
In the clinic
Coronavirus